New CAR T Therapy Shows Promise for Glioblastoma | Mass General Brigham [Video]

A collaborative project to bring the promise of cell therapy to patients with a deadly form of brain cancer has shown dramatic results among the first patients to receive the novel treatment. In a paper published today in The New England Journal of Medicine, researchers from the Mass General Cancer Center, a member of the Mass General Brigham healthcare system, shared the results for the first three patient cases from a phase 1 clinical trial evaluating a new approach to CAR-T therapy for glioblastoma (GBM).

Learn more: https://www.massgeneralbrigham.org/en/about/newsroom/press-releases/car-t-therapy-clinical-trial-for-glioblastoma-patients

Subscribe Link: https://www.youtube.com/channel/UCYrLjATd88gPwIKntCoR0WQ?sub_confirmation=1

About Mass General Brigham:
Mass General Brigham combines the strength of two world-class academic medical centers, five nationally ranked specialty hospitals, 11 community hospitals, and dozens of health centers. Our doctors and researchers accelerate medical breakthroughs and drive innovations in patient care. They are leaders in medical education, serving as Harvard Medical School faculty and training the next generation of physicians. Mass General Brigham’s mission is to deliver the best, affordable health care to patients everywhere. Together, we transform the health of our communities and beyond.

#MassGeneralBrigham #CancerResearch

Visit Mass General Brigham: https://www.massgeneralbrigham.org/

Find us on social:
Twitter: https://twitter.com/MassGenBrigham
Instagram: https://www.instagram.com/massgeneralbrigham/
Facebook: https://www.facebook.com/MassGeneralBrigham/
LinkedIn: https://www.linkedin.com/company/mass-general-brigham/

New CAR T Therapy Shows Promise for Glioblastoma | Mass General Brigham
https://youtu.be/uDoTf0WneE8